Monday, April 19, 1999
AUSTIN - Texas Attorney General John Cornyn today announced a $15,000 settlement with Quest IV Health Products to end its false health claims. Quest IV agreed to stop making the unapproved drug claims for the products, refund consumers who purchased these products, and pay the State $15,000.00 in attorneys fees.
In the marketing and labeling of Restores+ and Caucasicum+, Quest IV represented that the product is effective in treating Attention Deficit Disorder (ADD), Attention Deficit Hyperactivity Disorder (ADHD), and specific symptoms related to these diseases. The company also markets Caucasicum+ as a treatment for alcoholism and heart disease. Neither drug is approved by the U.S. Food and Drug Administration for the treatment of any disease.
Under the terms of the settlement, the company is required to stop the sale and distribution of Restores+, Caucasicum+ for the treatment of ADD, ADHD, alcoholism, heart disease, cancer or any other disease. In addition, the company may not represent that Restores+ or Caucasicum+ is an effective cure or treatment of any disease unless the claims are approved by the U.S. Food and Drug Administration.
Quest IV agreed to refund the full purchase price to any consumer who requests a refund, within 90 days of April 19, 1999, and presents a proof of purchase of Restores+ or Caucasicum+ or returns the product. Requests for refunds should be sent to Quest IV Health Products, Inc. 2106 West Pioneer Parkway, Suite 131, Arlington, Texas 76013.
This case was handled by the Dallas Office of the Consumer Protection Division. The settlement was filed in the 162nd District Court in Dallas.
- 30 -